Topical Review of Experience with Current Diagnostic Systems
Schizophrenia and Related Disorders: Experience with Current Diagnostic SystemsBertelsen A.
WHO Collaborating Centre for Research and Training in Mental Health, Department of Psychiatric Demography, Institute for Basic Psychiatric Research, Aarhus Psychiatric Hospital, Risskov, Denmark
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Schizophrenia and related disorders include a variety of psychotic disorders in the major classification systems, ICD-10 and DSM-IV, with only partial concordance between the two systems. They both rely on demonstrated reliability, but which disorders are the most valid still has to be determined. Particularly for the ICD-10 disorders, only few studies examining external validity have appeared. Disorders of uncertain validity include ‘schizo-affective disorders’ which in ICD-10 contain the DSM-IV psychotic mood disorders with first-rank symptoms or bizarre delusions; ICD-10 ‘schizotypal disorder’ which in DSM-IV is a personality disorder; the ICD-10 ‘acute and transient psychotic disorders’ and the DSM-IV ‘brief psychotic disorder’. Concerning diagnostic criteria, the reliability and validity of Schneiderian first-rank symptoms, ‘bizarre’ delusions and the Bleulerian ‘negative’ symptoms have been questioned. Validity studies in these areas are needed before it will be possible to provide major reconstructions for future diagnostic systems. One may hope that, eventually, one common worldwide psychiatric classification will be available.
© 2002 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.